Submission Details
| 510(k) Number | K122252 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 27, 2012 |
| Decision Date | November 13, 2013 |
| Days to Decision | 474 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
K122252 is an FDA 510(k) clearance for the SPACE CHAMBER PLUS COMPACT SPACE CHAMBER PLUS. This device is classified as a Holding Chambers, Direct Patient Interface (Class II — Special Controls, product code NVP).
Submitted by Medical Developments International (St Leonards, AU). The FDA issued a Cleared decision on November 13, 2013, 474 days after receiving the submission on July 27, 2012.
This device falls under the Anesthesiology FDA review panel. Regulated under 21 CFR 868.5630. Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles.
| 510(k) Number | K122252 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | July 27, 2012 |
| Decision Date | November 13, 2013 |
| Days to Decision | 474 days |
| Submission Type | Traditional |
| Review Panel | Anesthesiology (AN) |
| Summary | Summary PDF |
| Product Code | NVP — Holding Chambers, Direct Patient Interface |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 868.5630 |
| Definition | Holding Chambers Are Devices That Are Used With Nebulizers And Metered Dose Inhalers And Are Comprised Of A Reservoir Into Which An Aerosol Medication Is Dispensed. A Holding Chamber Uses A Valved Mouthpiece Through Which The Patient Inhales The Dispensed Medication. Holding Chambers Are Intended To Minimize Delivery Of Large Aerosolized Particles |